GB202210305D0 - Treatment of fragile x syndrome - Google Patents

Treatment of fragile x syndrome

Info

Publication number
GB202210305D0
GB202210305D0 GBGB2210305.5A GB202210305A GB202210305D0 GB 202210305 D0 GB202210305 D0 GB 202210305D0 GB 202210305 A GB202210305 A GB 202210305A GB 202210305 D0 GB202210305 D0 GB 202210305D0
Authority
GB
United Kingdom
Prior art keywords
fragile
syndrome
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2210305.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Healx Ltd
Original Assignee
Healx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healx Ltd filed Critical Healx Ltd
Priority to GBGB2210305.5A priority Critical patent/GB202210305D0/en
Publication of GB202210305D0 publication Critical patent/GB202210305D0/en
Priority to PCT/GB2023/051841 priority patent/WO2024013505A1/en
Ceased legal-status Critical Current

Links

GBGB2210305.5A 2022-07-13 2022-07-13 Treatment of fragile x syndrome Ceased GB202210305D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2210305.5A GB202210305D0 (en) 2022-07-13 2022-07-13 Treatment of fragile x syndrome
PCT/GB2023/051841 WO2024013505A1 (en) 2022-07-13 2023-07-13 Ibudilast and gaboxadol for the treatment of fragile x syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2210305.5A GB202210305D0 (en) 2022-07-13 2022-07-13 Treatment of fragile x syndrome

Publications (1)

Publication Number Publication Date
GB202210305D0 true GB202210305D0 (en) 2022-08-24

Family

ID=84539918

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2210305.5A Ceased GB202210305D0 (en) 2022-07-13 2022-07-13 Treatment of fragile x syndrome

Country Status (1)

Country Link
GB (1) GB202210305D0 (en)

Similar Documents

Publication Publication Date Title
IL284363A (en) Rna-editing oligonucleotides for the treatment of usher syndrome
EP4119562A4 (en) Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome
EP4117704A4 (en) Cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections
IL299889A (en) Methods and compositions for treatment of fragile x syndrome
GB202301901D0 (en) Treatment of fragile x syndrome
GB202210305D0 (en) Treatment of fragile x syndrome
ZA202210315B (en) Peptide for the treatment of cytokine storm syndrome
IL290404A (en) Treatment of fragile x syndrome
EP3737703A4 (en) Treatment of fragile x syndrome
IL291146A (en) Treatment of hidradenitis with jak inhibitors
GB202305591D0 (en) Treatment of angelman syndrome
GB202305595D0 (en) Treatment of angelman syndrome
GB202305590D0 (en) Treatment of angelman syndrome
EP4146227A4 (en) Treatment of viral infections
GB202008094D0 (en) Treatment of infections
GB202304840D0 (en) Treatment of pitt-hopkins syndrome
GB202304838D0 (en) Treatment of pitt-hopkins syndrome
EP4090344A4 (en) Methods of treating fragile x syndrome with reelin
GB202108260D0 (en) Treatment of severe acute respiratory syndrome
GB202107095D0 (en) Treatment of severe acute respiratory syndrome
GB202315695D0 (en) TReatment of cariomyopathy
GB202212506D0 (en) Treatment of covid-19
IL284749A (en) Treatment of pitt-hopkins syndrome
EP4101448A4 (en) Composition comprising rilmenidine compound as active ingredient for treatment of fragile x syndrome or related developmental disability
GB202312669D0 (en) Treatment of viral infections

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)